[Course and treatment of herpervirus hominis infections. II. Therapy].
D000906:Antibodies; D000998:Antiviral Agents / Q000494:pharmacology / Q000627:therapeutic use; D055598:Chemical Phenomena; D002621:Chemistry; D004261:DNA Replication / Q000187:drug effects; D004357:Drug Synergism; D006561:Herpes Simplex / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007372:Interferons; D018139:Simplexvirus / Q000187:drug effects* / Q000254:growth & development / Q000276:immunology / Q000378:metabolism / Q000472:pathogenicity; D013454:Sulfoxides / Q000494:pharmacology / Q000627:therapeutic use; D013997:Time Factors; D014529:Uridine / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D014611:Vaccination; D014762:Viral Interference; D014779:Virus Replication / Q000187:drug effects
D000906:Antibodies; D000998:Antiviral Agents; D013454:Sulfoxides; D007372:Interferons; D014529:Uridine
Verlauf und Behandlung der Infektionen mit dem Herpesvirus hominis II. Therapie.